-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Procter & Gamble reported solid Q3 results with net sales rising 7% to $21.2B, including 3% organic growth driven equally by volume and pricing gains, marking improved momentum across all segments. However, profitability came under pressure as gross margin contracted 150 bps to 49.5% due to unfavorable mix and reinvestments, while core EPS rose 3% to $1.59. The results demonstrate P&G's strong brand portfolio and operating excellence, with valuation appearing less stretched. Management maintained FY guidance ranges but expects results toward the lower end due to increased innovation investments and ongoing cost pressures. Looking ahead, commodity costs and tariffs are expected to create a combined $0.25 per share headwind for the full year. The stock trades at 21x FY 26 consensus estimates, below its three-year average forward P/E of 23.2x, reflecting improved relative valuation amid the company's continued market resilience and cash generation strength.